Funding Opportunity
Announcement (FOA) Number RFA-AI-14-015
Funding Opportunity
Purpose
The purpose of this FOA is to
solicit applications to support early stage translational research focused on
the development of novel therapeutics against select anaerobic protozoal
pathogens.
Treatment of
infectious diseases caused by anaerobic protozoal pathogens is compromised by
limited effective therapeutic options and/or development of resistance. There
is a critical need for development of new therapeutic approaches to treat these
clinically-important diseases, including novel approaches such as small
molecule antimicrobials and/or adjunctive therapeutics targeting resistance
mechanisms. This initiative encourages the discovery, preclinical development
and/or validation of novel interventions for the treatment of infectious
diseases caused by select anaerobic protozoa (amebiasis, giardiasis,
trichomoniasis and diseases caused by free-living amoebae).
Open Date (Earliest
Submission Date) September 30, 2014
Letter of Intent Due
Date September 30, 2014
Application Due
Date October 30, 2014, by 5:00 PM
local time of applicant organization
Earliest Start Date July 2015
Foreign Institutions Non-domestic (non-U.S.)
Entities (Foreign Institutions) are eligible to apply.
Award Budget
R21 Phase: 2 two
years
Direct costs are limited to $275,000 over the 2 years; a maximum of $200,000 in direct costs is allowed in any single year.
R33 Phase: Direct costs are limited to $300,000 per year and cannot exceed
3 years.
Consortia F&A (Indirect Costs/Overheads) are not included in the direct costs.
The NIAID
anticipates that a maximum of 50% of the funded R21 phase
awards will progress to the R33 award.
Letter of Intent
Although a letter of
intent is not required, is not binding, and does not enter into the review of a
subsequent application, the information that it contains allows IC staff to
estimate the potential review workload and plan the review.
By the date listed in Part 1. Overview
Information, prospective applicants are asked to submit a letter of
intent that includes the following information:
·
Descriptive title of
proposed activity
·
Name(s), address(es),
and telephone number(s) of the PD(s)/PI(s)
·
Names of other key
personnel
·
Participating
institution(s)
·
Number and title of
this funding opportunity
The letter of intent
should be sent to:
Annie Walker-Abbey,
PhD
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-451-2671
Fax: 301-480-2408
Email: aabbey@niaid.nih.gov
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-451-2671
Fax: 301-480-2408
Email: aabbey@niaid.nih.gov
If you want more information about the grant opportunity or need help with your application, please contact us at the Office of Research Services:
Paul: paul.ada@mahidol.ac.th
Tel; 023069125 or 023069126
